Skip to content
Clinical Trials – home

Centre Hospitalier De Versailles

Verifiedinfo

France 177 Rue De Versailles, Le Chesnay, 78150 Le Chesnay-Rocquencourt, France

  • 60 trials recruiting
  • Acute myeloid leukaemia · Plasma cell myeloma · Acute lymphocytic leukaemia
  • Adults and children

About Specializations

Centre Hospitalier De Versailles in Le Chesnay-Rocquencourt, France specialises in clinical trials of conditions such as Acute myeloid leukaemia, Plasma cell myeloma, Acute lymphocytic leukaemia, Chronic myeloid leukaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for conditions such as acute myocardial infarction and cardiac failure. The center's research aims to improve patient outcomes through advanced therapeutic strategies.

  • Acute Myocardial Infarction
  • Cardiac Remodeling
  • Heart Failure Management

By integrating cutting-edge therapies like evolocumab and dapagliflozin, the center is enhancing the standard of care for cardiovascular patients.

Oncology and Hematology

Specializing in oncology and hematology, the center conducts pivotal trials in multiple myeloma, chronic myeloid leukemia, and acute lymphoblastic leukemia. These studies are crucial for developing new treatment protocols and improving survival rates.

  • Multiple Myeloma
  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia

Through the exploration of novel drug combinations and targeted therapies, the center is advancing the field of cancer treatment.

Neurology and Stroke

The center is pioneering research in neurology, with a focus on stroke management and recovery. By investigating new thrombolytic agents and treatment windows, the center aims to enhance neurological outcomes for stroke patients.

  • Acute Ischaemic Stroke
  • Neurological Recovery
  • Thrombolytic Therapy

Innovative approaches in stroke care are being developed to improve patient quality of life and reduce long-term disability.

Respiratory and Infectious Diseases

Focusing on respiratory and infectious diseases, the center is conducting research on conditions like severe influenza and chronic obstructive pulmonary disease (COPD). These studies aim to optimize treatment regimens and improve patient outcomes.

  • Severe Influenza
  • Chronic Obstructive Pulmonary Disease
  • Infectious Disease Management

By exploring new therapeutic strategies, the center is enhancing the management of complex respiratory conditions.

Immunology and Autoimmune Disorders

The center is advancing the field of immunology through research on autoimmune disorders such as giant cell arteritis and familial Mediterranean fever. These studies focus on novel treatments to improve patient care and disease management.

  • Giant Cell Arteritis
  • Familial Mediterranean Fever
  • Autoimmune Disease Management

Innovative therapies are being developed to target the underlying mechanisms of autoimmune diseases, offering hope for improved patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
177 Rue De Versailles, Le Chesnay78150 Le Chesnay-RocquencourtFrance
Recruiting now
60 trials
Conditions studied
91
Partner status
Verified

More sites in Le Chesnay-RocquencourtFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

124 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Hepatic fibrosis+2

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Efruxifermin
  • Sponsor:Akero Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Efruxifermin
  • Sponsor:Akero Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Asparaginase
  • Sponsor:Amgen Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Kura Oncology Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Assistance Publique Hopitaux De Paris
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.